Litcius/Paper detail

Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI

Sarah Jane Schwarzenberg, Phuong T. Vu, M. Skalland, Lucas R. Hoffman, Christopher E. Pope, Daniel Gelfond, Michael R. Narkewicz, David P. Nichols, Sonya L. Heltshe, Scott H. Donaldson, Carla A. Frederick, Andrea Kelly, Jessica E. Pittman, Félix Ratjen, Margaret Rosenfeld, Scott D. Sagel, George M. Solomon, Michael S. Stalvey, John P. Clancy, Steven M. Rowe, Steven D. Freedman

2022Journal of Cystic Fibrosis123 citationsDOIOpen Access PDF

Topics & Concepts

IvacaftorCystic fibrosisMedicineInternal medicineCystic fibrosis transmembrane conductance regulatorCystic Fibrosis Research AdvancesGastrointestinal motility and disordersRespiratory and Cough-Related Research
Elexacaftor/tezacaftor/ivacaftor and gastrointestinal outcomes in cystic fibrosis: Report of promise-GI | Litcius